We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$134M
AUM Growth
+$13.4M
Cap. Flow
+$5.63M
Cap. Flow %
4.21%
Top 10 Hldgs %
30.08%
Holding
84
New
4
Increased
49
Reduced
18
Closed
2

Top Buys

Rank Stock Value
1
EVRG icon
Evergy
EVRG
+$3.32M
2
PFE icon
Pfizer
PFE
+$1.33M
3
NEM icon
Newmont
NEM
+$774K
4
B
Barrick Mining
B
+$644K
5
BMY icon
Bristol-Myers Squibb
BMY
+$572K

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.33%
2 Healthcare 15.26%
3 Technology 15.03%
4 Materials 10.09%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
26
Duke Energy
DUK
$98.4B
$3.21M 2.39%
33,158
+700
+2% +$66.4K
BMY icon
27
Bristol-Myers Squibb
BMY
$132B
$3.2M 2.39%
59,064
+11,219
+23% +$572K
PFE icon
28
Pfizer
PFE
$142B
$3.11M 2.33%
112,221
+48,106
+75% +$1.33M
NTR icon
29
Nutrien
NTR
$33.9B
$3.06M 2.29%
56,425
+7,730
+16% +$403K
JNJ icon
30
Johnson & Johnson
JNJ
$617B
$2.99M 2.23%
18,874
-123
-0.6% -$19.6K
SO icon
31
Southern Company
SO
$109B
$1.85M 1.38%
25,833
+257
+1% +$17.7K
BILZ icon
32
PIMCO Ultra Short Government Active ETF
BILZ
$1B
$1.2M 0.89%
11,840
-4,615
-28% -$466K
GLD icon
33
SPDR Gold Trust
GLD
$133B
$1.06M 0.79%
5,167
+32
+0.6% +$6.14K
DE icon
34
Deere & Co
DE
$162B
$1.01M 0.75%
2,448
SMG icon
35
ScottsMiracle-Gro
SMG
$3.97B
$973K 0.73%
13,051
+1,500
+13% +$93.2K
AGX icon
36
Argan
AGX
$8.13B
$959K 0.72%
18,973
+636
+3% +$29.8K
HAE icon
37
Haemonetics
HAE
$3.85B
$853K 0.64%
9,999
+1,219
+14% +$95.7K
CTVA icon
38
Corteva
CTVA
$59.8B
$844K 0.63%
14,637
+820
+6% +$42.4K
ZBRA icon
39
Zebra Technologies
ZBRA
$13.7B
$819K 0.61%
2,718
+3
+0.1% +$803
CFR icon
40
Cullen/Frost Bankers
CFR
$10.3B
$693K 0.52%
6,156
+327
+6% +$34.9K
MTRX icon
41
Matrix Service
MTRX
$320M
$676K 0.5%
51,849
-26,590
-34% -$298K
MCK icon
42
McKesson
MCK
$101B
$665K 0.5%
1,239
JPM icon
43
JPMorgan Chase
JPM
$933B
$630K 0.47%
3,146
-48
-2% -$8.66K
SCHW
44
Charles Schwab
SCHW
$181B
$624K 0.47%
8,630
+294
+4% +$19.4K
SXI icon
45
Standex International
SXI
$3.48B
$616K 0.46%
3,378
+6
+0.2% +$969
WY icon
46
Weyerhaeuser
WY
$16.9B
$585K 0.44%
16,291
+159
+1% +$5.38K
HON icon
47
Honeywell
HON
$76.7B
$564K 0.42%
2,916
KEX icon
48
Kirby Corp
KEX
$7.08B
$563K 0.42%
5,908
+355
+6% +$30K
HD icon
49
Home Depot
HD
$332B
$555K 0.41%
1,447
+38
+3% +$13.9K
XOM icon
50
ExxonMobil
XOM
$651B
$547K 0.41%
4,707
+827
+21% +$86.5K

Similar funds

Keene & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Keene & Associates held 84 positions worth $134M, up 11% from $120M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Keene & Associates deployed $5.63M of net new capital in Q1 2024, opening 4 new positions and adding to 49 existing holdings. Its largest new stake was Evergy: 64,935 shares worth $3.47M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intel, an estimated $1.01M trimmed.

  • Keene & Associates's largest Q1 2024 buy was Evergy: 64,935 shares worth $3.47M.
  • Keene & Associates added most to Pfizer in Q1 2024, an estimated $1.33M increase.
  • Keene & Associates's biggest Q1 2024 reduction was Intel, cutting an estimated $1.01M.
  • Keene & Associates fully exited Organon & Co in Q1 2024, selling an estimated $1.08M.
  • Keene & Associates's ten largest holdings make up 30% of its $134M portfolio in Q1 2024.
  • Keene & Associates opened 4 new positions and closed 2 in Q1 2024.
  • Keene & Associates's portfolio value rose 11% quarter-over-quarter to $134M.

Based on Keene & Associates's 13F filing for Q1 2024, filed 24 Apr 2024.